Corcept: Use of Charitable Foundations Could Draw DOJ Scrutiny

Published on Jan 24, 2023

Corcept Therapeutics Incorporated (CORT) appears to have provided patients with free Korlym or financial assistance through charitable foundations to give them access to the company’s expensive flagship drug.  After those people got access to the drug, the company aggressively pushed them to enroll in a commercial or government health plan that would pay for future […]

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

Copyright ©2024 The Capitol Forum. All Rights Reserved.